Friday, May 27, 2011

Positive Reinforcement Boosts Analgesic Effects

Placebo Convincing new evidence demonstrates how patients’ beliefs and expectations of benefit or adverse effects can directly influence response to opioid analgesic therapy. This has important implications for the role of healthcare providers in helping to shape and optimize patient response to any pain relieving treatment.

Researchers from Britain and Germany examined how divergent expectancies may alter the efficacy of potent opioid analgesia. Efficacy of a fixed concentration of the intravenous (IV) μ-opioid agonist remifentanil in ameliorating a heat pain stimulus was assessed in each of 22 healthy volunteers under 3 experimental conditions. Besides subject self-reports of pain decrease/increase, functional magnetic resonance imaging (fMRI) was used to record brain activity to corroborate subjective responses and to reveal underlying neural mechanisms. The procedure was as follows…

Thursday, May 26, 2011

Women, Pain Relievers, & Suicide: An Epidemic?

Suicide With all the emphasis lately on the alleged epidemic of overdoses and deaths associated with prescription opioids an overlooked dark secret is that pain relievers — both Rx and over-the-counter — are increasingly used in suicide attempts, particularly by women. Better strategies than prescriber education and restricting access to these medications are needed for effectively dealing with this other “epidemic.”

A newly published nationwide study in the U.S. shows that from 2005 to 2009 (the most recent year with available data) emergency department (ED) visits for drug related suicide attempts by women of all ages increased from 92,682 to 120,418. Of particular concern, suicide attempts by women aged 50 and older rose by 49% — from 11,235 to 16,757 during the 5-year period — the greatest increase for any age group [SAMHSA 2011].

Wednesday, May 25, 2011

Hand Pain? Cross Your Arms to Confuse the Brain.

New research suggests that if your hand hurts, simply crossing your arms will confuse the brain and reduce the pain intensity. However, don’t go smashing your thumb to put this to the test — there were limitations of this research to consider first.

Hands Writing in the June 2011 edition of the journal Pain, an international team of researchers report using a laser to produce brief pin pricks of “pure pain” (pain without touch) on the hands of a small group of 8 volunteers [Gallace et al. 2011]. Pain stimuli were then repeated after subjects crossed their arms at the wrists. Subjects rated their pain during each condition and their brain responses to the pain were measured via electroencephalography (EEG).

Naltrexone Effective Therapy for Crohn's Disease

Naltrexone Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract causing abdominal pain, diarrhea, GI bleeding, and weight loss. Current therapies for the condition reduce the inflammation but some are expensive and may incur rare but serious side effects, including infections and lymphoma.

Prior research has suggested that endorphins and enkephalins, components of the endogenous opioid system, may play a role in the development or continuation of inflammation. Therefore, researchers at the Pennsylvania State University College of Medicine studied 40 patients with active Crohn's disease to determine possible benefits of naltrexone — an opioid antagonist — in treating the condition [Smith et al. 2011]. In a double-blind, placebo controlled trial patients were randomized to receive either low-dose oral naltrexone (4.5 mg) or placebo daily for 12 weeks. All subjects then continued on naltrexone for an additional 12 weeks.

Friday, May 20, 2011

Risks of Misinterpreting “Risk” in Pain Research

PainResearch Part 6 – Understanding RR, RRR, ARR, & NNT

An understanding of outcomes presented in pain research studies as “risk statistics,” which are special estimates of effect, is central to evidence-based medicine approaches. Yet, this can be confusing, since authors often do not portray or discuss study results involving these measures in everyday terms that can be applied in pain practice. Therefore, being able to interpret risk effects — denoted as RR, RRR, ARR, or NNT — is vital for making sense of pain research.

Thursday, May 19, 2011

Homeopathy for Arthritis: Help, Harm, or Hoax?

CAM The healing art of homeopathy dates back several centuries, yet it remains controversial. A recently reported clinical trial demonstrated that homeopathic remedies were of no help for treating painful rheumatoid arthritis (RA), but benefits of the homeopathic consultation itself were substantial. Yet, there are serious deficiencies in this research that leave open the question of whether homeopathic remedies might be of value in treating RA.

Homeopathy is a form of complementary and alternative medicine (CAM) in which practitioners treat patients using highly diluted preparations of agents, either individually or in combination, that are believed to exert healing effects for specific disorders. It originated in the late 18th Century and, apart from assessing symptoms, homeopathic practitioners examine all aspects of a patient’s physical, psychological, and spiritual state during an extensive consultation to determine appropriate therapeutic remedies.

Friday, May 13, 2011

NSAIDs Deadly for Heart Attack Survivors?

NSAIDs When heart attack survivors or those with heart disease take nonsteroidal anti-inflammatory drugs, or NSAIDs, it puts them at higher risk for recurring heart attack or death, according to a new study in Circulation, a journal of the American Heart Association. Results of the new research suggest that even short-term use of these pain relievers is unsafe for these patients with pain.

The research team in Denmark observed that, despite the fact that certain NSAIDs are contraindicated in patients with established cardiovascular disease, many still receive these analgesics for short periods of time [Olsen et al. 2011]. And, this may be especially so in countries like the United States where many NSAIDs are available without prescription. Therefore, the researchers conducted a large-scale study to assess the duration of NSAID treatment and cardiovascular mortality risks in a nationwide cohort of patients with prior myocardial infarction (MI, or heart attack).

Factors in Opioid-Rx Noncompliance Examined

Opioid Rx It is well known that non-adherence to prescribed opioid regimens can decrease both the safety and effectiveness of this analgesic therapy. A new study examined factors associated with such noncompliance and found that somatization strongly influenced over- and underuse of medication. This may suggest strategies for more effective opioid prescribing, but there were some important limitations of this research.

Thursday, May 12, 2011

Florida Faces Challenges of Pervasive Pain

Chronic Pain According to a new survey from the American Osteopathic Association (AOA), more than 85% of Florida residents say they, or someone they care for, have experienced pain in the past month. This comes at a unique time in Florida when the state legislature is revamping health policies and introducing safeguards to prevent prescription analgesic abuses, which may inadvertently thwart access to those pain medications.

In a news release [PRNewswire, 5/10/2011], Joseph A. Giaimo, DO — Assistant Clinical Professor at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale — said, "Chronic pain is a serious public health issue. Many Florida residents live with pain because they believe it is just a part of the aging process or fear their pain cannot be treated. We're encouraging patients to take the first step to finding relief by openly discussing pain with their physician and then working together to develop an individualized treatment plan."

Saturday, May 7, 2011

Activity vs Disability in Low-Back Pain Assessed

Back Pain It is often assumed that patients with disability related to low-back pain (LBP) will have reduced physical activity, and treatment emphasizes maintaining or gradually increasing activity. Now, researchers have found that there is no significant correlation between physical activity level and disability in acute/subacute LBP. In chronic LBP, as might be expected, persons with higher levels of disability are less likely to be physically active, and whether increased activity would be helpful for them is largely unknown.

Reporting in the journal Pain, an international team of investigators conducted a meta-analysis to examine the relationship between physical activity and disability in LBP [Lin et al. 2011]. Their literature search included studies up to May 2010 that measured both disability (eg, with the Roland Morris Disability Questionnaire) and physical activity (eg, by accelerometry) in patients with non-specific LBP.

Friday, May 6, 2011

Acetaminophen the Most Perilous Analgesic?

Acetaminophen According to a pair of studies in an upcoming edition of the American Journal of Preventive Medicine, a surprising majority of Americans do not know what is in their over-the-counter (OTC) analgesics. Most people do not bother to read warnings on product labels, which is particularly troublesome with acetaminophen. However, even more alarming is that 70% of acetaminophen poisoning cases are intentional attempts to inflict self harm.

In the first study, researchers from Northwestern University in Chicago note that acetaminophen overdose in the United States has surpassed viral hepatitis as the leading cause of acute liver failure, and misuse contributes to more than 30,000 hospitalizations annually [King et al. 2011]. Acetaminophen (known as paracetamol outside the U.S.) is an ingredient in more than 600 OTC analgesics and a root cause of many accidental poisonings is likely a poor understanding of medication labeling or a failure to recognize the consequences of exceeding the recommended maximum daily dosage.

Sunday, May 1, 2011

Pain Research: Confidence in Confidence Intervals

Part 5 – Helping to Determine Clinical Significance

Whether or not outcomes of pain research studies are found to be statistically significant tells only part of the story, and a small part at that. What healthcare providers and their patients really need to know is whether the outcomes have importance for improving pain practice. And, for determining such clinical significance, understanding a statistical concept called the “Confidence Interval” can be critically helpful.

StatisticsFear This fifth article in our series on “Making Sense of Pain Research” begins examining how data can be mathematically — that is, statistically — interpreted for providing answers to clinical questions in pain management. When many people hear the word “statistics” they want to hide, and even experienced readers of research often suffer from a certain amount of “statistiphobia.” However, it is not necessary to be a biostatistician to understand and apply basic statistical concepts for the interpretation of pain research; yet, it will require some careful study.

Will Opioid Prescribers Comply with REMS?

Now that the FDA’s Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting opioid analgesics has been announced [see UPDATE here], an important question is: Will prescribers eagerly comply with requirements or will many choose instead to stop prescribing these analgesics for their patients with pain? Surveys conducted prior to the FDA’s recent action may offer some clues as to what might happen.

To assess the likely impact of REMS on opioid prescribing, researchers at the University of Pennsylvania conducted a survey sent via e-mail in January 2009 to members of the Pennsylvania Academy of Family Physicians [Slevin et al. 2011]. These clinicians were asked to respond to questions regarding their current opioid prescribing, and how various components of REMS might alter this practice in the future.

NSAIDs Reduce Effectiveness of Antidepressants?

Researchers at the Rockefeller University in New York, have shown that nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the effectiveness of selective serotonin reuptake inhibitors, or SSRIs. Could this discovery, published online in the Proceedings of the National Academy of Sciences, explain cases of depressed patients with pain who do not respond as expected to antidepressant therapy when they also are taking over-the-counter analgesics?

This possible negative interaction was first explored by the researchers in animal experiments and then confirmed in humans. The investigators treated mice with antidepressants in the presence or absence of NSAIDs and found that behavioral responses typically sensitive to antidepressant effects were inhibited in the animals administered NSAIDs. Biochemical assays also found abnormalities associated with the combination of NSAIDs and antidepressants.